Evaluating platelet function after cardiac surgery using different blood salvage devices

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of two different cell saver devices used during cardiac surgery to preserve platelet number and function. Intraoperative cell salvage is employed to minimize the need for donor blood transfusions, but the processing can lead to a loss of plasma, which is crucial for optimal coagulation. The researchers will compare the performance of an in-house device and the i-Sep SAME device in maintaining platelet integrity during the procedure. The goal is to determine which device better supports patient recovery post-surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \>18 years
* Elective high risk cardiac surgery with cardiopulmonary bypass usage
* Cardiopulmonary bypass time \> 120 minutes
* Written informed consent

Exclusion Criteria:

* Preoperative use of oral or intravenous anti-coagulants or antiplatelet agents (except aspirin)
* Inability to understand and sign the informed consent form (e.g. language problems, dementia, mental disorders).

Where it's running

• Department of Anesthesiology and Pain Medicine
  Bern, Switzerland Recruiting

Study contacts

• Study coordinator: Fabio Barattiero, MD
• Email: fabio.barattiero@insel.ch
• Phone: 004131632111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using cangrelor to improve outcomes in patients with cardiogenic shock on ECMO

  This study is testing if adding a medication called cangrelor can help patients in cardiogenic shock on ECMO have better outcomes while reducing bleeding risks during their treatment.

  Recruiting Phase 2 IRCCS San Raffaele · Milan, Italy · NCT06792643

• Observational study of blood clotting and bleeding disorders in Chinese patients

  This study looks at blood clotting and bleeding problems in Chinese patients to see how common they are and what factors might affect them.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality and 4 other locations · NCT06727669

• Understanding hemorrhage subtypes in perimesencephalic SAH and basilar artery perforator aneurysms

  This study tests whether different bleeding patterns in pmSAH, including potential basilar artery perforator aneurysms, relate to patient outcomes using a patient-reported EQ-5D measure.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern · NCT07923084

• Pediatric Outpatient Health Data Cohort in Switzerland

  This study tests the PROS-CH data-collection system in pediatric primary care to see if routine tools can build a useful cohort of children under age 2 for common health issues.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern · NCT07911228

• Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes

  This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.

  Recruiting at 5 sites Insel Gruppe AG, University Hospital Bern · Zabrze and 4 other locations · NCT07852221

• Left vs right subthalamic nucleus deep brain stimulation: how it changes thinking and mood in Parkinson’s

  This study tests whether turning DBS on the left or the right side of the brain changes cognition and mood in people with Parkinson’s disease.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern · NCT07777419

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.